BRUSSELS (Reuters) - The European Commission on Tuesday said it had approved the proposed merger between U.S. healthcare information firm IMS Health (>> IMS Health Holdings Inc) and U.S. contract medical research provider Quintiles (>> Quintiles Transnational Holdings Inc).
The Commission said the proposed transaction would raise no competition concerns.
(Reporting by Alissa de Carbonnel, editing by Julia Fioretti)